Family · skin
GHK-Cu
Copper peptide / Copper tripeptide-1 (Glycyl-L-Histidyl-L-Lysine-Copper(II))
GHK-Cu is a naturally occurring copper complex of the human tripeptide GHK (glycyl-L-histidyl-L-lysine), found in plasma, saliva and urine, with levels declining with age. Preclinically, it acts as a broad signaling molecule rather than a single-target drug: it delivers copper needed as a cofactor for antioxidant enzymes (e.g., superoxide dismutase), modulates the balance of matrix metalloproteinases and their inhibitors to support extracellular-matrix remodeling, stimulates fibroblast collagen, elastin, and glycosaminoglycan production, and has been reported in gene-expression screens to shift the activity of thousands of genes toward patterns associated with tissue repair and away from patterns associated with inflammation and fibrosis. It also appears to support angiogenesis and hair-follicle stem cell activity in animal/cell models.
GHK-Cu is one of the better-studied cosmetic peptides, with decades of in vitro, animal, and topical human cosmetic-formulation research. Topical human studies (mostly small, industry-linked, or open-label) suggest improvements in skin firmness, fine lines, and photodamage markers with regular cosmetic use. Evidence for injectable/systemic use in humans is far more limited than for topical cosmetic use, and rigorous, independent, large-scale randomized controlled trials for injectable or 'anti-aging' systemic use are lacking. Most robust mechanistic and gene-expression data come from cell culture and animal models, not confirmed clinical outcomes in people.
- Widely used topically in cosmetic/dermatological formulations for skin firmness and photoaging
- Studied for wound healing and reduction of scarring in preclinical and some clinical wound models
- Studied for hair follicle and hair growth stimulation in preclinical models
- Explored as a general tissue-repair and antioxidant-supporting signaling peptide
Educational overview only — no dosing instructions in the public hub.
Topical GHK-Cu in approved cosmetic concentrations has a long history of use with a generally favorable safety profile and minimal reported irritation in most formulations. Injectable or high-concentration systemic use is far less studied in humans; copper is a redox-active metal and excess systemic copper exposure carries theoretical oxidative-stress and toxicity concerns, particularly with unregulated dosing or impure product. As with any unapproved injectable peptide, sourcing, sterility, and purity are not guaranteed outside pharmaceutical-grade cosmetic products.
For any non-topical/cosmetic-grade product, look for an independent third-party Certificate of Analysis (CoA) confirming purity via HPLC, accurate peptide quantification versus label claim, and mass spectrometry (MS) identity confirmation — copper content and chelation stability should also ideally be verified, since 'GHK' without confirmed copper complexation is a different substance from GHK-Cu.
Approved and widely used as a cosmetic ingredient (topical skincare) in the EU, US, and most jurisdictions, where it is regulated as a cosmetic ingredient rather than a drug. It is not approved as a prescription drug for injectable or systemic therapeutic use anywhere; injectable/research forms sold outside cosmetic channels are typically labeled 'Research Use Only (RUO), not for human consumption.'
Frequently asked questions
- What is GHK-Cu used for?
- Widely used topically in cosmetic/dermatological formulations for skin firmness and photoaging. Studied for wound healing and reduction of scarring in preclinical and some clinical wound models. Studied for hair follicle and hair growth stimulation in preclinical models. Explored as a general tissue-repair and antioxidant-supporting signaling peptide. GHK-Cu is one of the better-studied cosmetic peptides, with decades of in vitro, animal, and topical human cosmetic-formulation research. Topical human studies (mostly small, industry-linked, or open-label) suggest improvements in skin firmness, fine lines, and photodamage markers with regular cosmetic use. Evidence for injectable/systemic use in humans is far more limited than for topical cosmetic use, and rigorous, independent, large-scale randomized controlled trials for injectable or 'anti-aging' systemic use are lacking. Most robust mechanistic and gene-expression data come from cell culture and animal models, not confirmed clinical outcomes in people.
- Is GHK-Cu legal in Europe?
- Approved and widely used as a cosmetic ingredient (topical skincare) in the EU, US, and most jurisdictions, where it is regulated as a cosmetic ingredient rather than a drug. It is not approved as a prescription drug for injectable or systemic therapeutic use anywhere; injectable/research forms sold outside cosmetic channels are typically labeled 'Research Use Only (RUO), not for human consumption.'
- What are the risks and side effects of GHK-Cu?
- Topical GHK-Cu in approved cosmetic concentrations has a long history of use with a generally favorable safety profile and minimal reported irritation in most formulations. Injectable or high-concentration systemic use is far less studied in humans; copper is a redox-active metal and excess systemic copper exposure carries theoretical oxidative-stress and toxicity concerns, particularly with unregulated dosing or impure product. As with any unapproved injectable peptide, sourcing, sterility, and purity are not guaranteed outside pharmaceutical-grade cosmetic products.
- How is the quality of GHK-Cu assessed?
- For any non-topical/cosmetic-grade product, look for an independent third-party Certificate of Analysis (CoA) confirming purity via HPLC, accurate peptide quantification versus label claim, and mass spectrometry (MS) identity confirmation — copper content and chelation stability should also ideally be verified, since 'GHK' without confirmed copper complexation is a different substance from GHK-Cu.